For citations:
Nyushko K.M., Alekseev B.Ya., Perepukhov V.M., Shevchuk I.M., Atduev V.A., Zdobnikov А.B., Venskel V.B., Gurin Е.V., Eremenko A.V., Belov I.V., Gavrilova V.D., Ismakov R.M., Prokhorov D.G., Nikitin R.V., Usinin E.A., Kopyltsov E.I., Leonov O.V., Leonov А.O. An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice. Cancer Urology. 2022;18(2):102-110. (In Russ.) https://doi.org/10.17650/1726-9776-2022-18-2-102-110
Email this article 